Skip to Main Content

Paper Details

Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma.
Clin Cancer Res
0
2023
IFN, Melanoma, PD-L1, Patients, STAT1, STAT1highPD-L1low, STAT1lowPD-L1high, cancer, human, human melanoma cell lines, melanoma, metastatic melanoma, pSTAT1Y701, patients, resistant states, tumor, tumors
Author NameAffiliation
Harriet M KlugerYale Cancer Center and Yale School of Medicine
Harriet M KlugerYale Cancer Center and Yale School of Medicine
David L RimmYale School of Medicine
  • 1 - 3

Datasets

Release 1.2